Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 2 |
2020 | 3 |
2021 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Deauville score: the Phoenix rising from ashes.
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1043-1045. doi: 10.1007/s00259-018-4215-9. Epub 2018 Nov 14.
Eur J Nucl Med Mol Imaging. 2019.
PMID: 30430194
No abstract available.
Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.
Rossi S, Toschi L, Castello A, Grizzi F, Mansi L, Lopci E.
Rossi S, et al.
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2310-2325. doi: 10.1007/s00259-017-3802-5. Epub 2017 Aug 16.
Eur J Nucl Med Mol Imaging. 2017.
PMID: 28815334
Review.
Item in Clipboard
Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors.
Castello A, Carbone FG, Rossi S, Monterisi S, Federico D, Toschi L, Lopci E.
Castello A, et al.
Cancers (Basel). 2020 Feb 19;12(2):487. doi: 10.3390/cancers12020487.
Cancers (Basel). 2020.
PMID: 32092983
Free PMC article.
Item in Clipboard
The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitors.
Castello A, Toschi L, Rossi S, Mazziotti E, Lopci E.
Castello A, et al.
J Cancer Res Clin Oncol. 2020 May;146(5):1235-1243. doi: 10.1007/s00432-020-03150-9. Epub 2020 Feb 11.
J Cancer Res Clin Oncol. 2020.
PMID: 32048008
Item in Clipboard
Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors.
Castello A, Rossi S, Toschi L, Lopci E.
Castello A, et al.
J Clin Med. 2021 Mar 17;10(6):1251. doi: 10.3390/jcm10061251.
J Clin Med. 2021.
PMID: 33803006
Free PMC article.
Item in Clipboard
Soluble PD-L1 in NSCLC Patients Treated with Checkpoint Inhibitors and Its Correlation with Metabolic Parameters.
Castello A, Rossi S, Toschi L, Mansi L, Lopci E.
Castello A, et al.
Cancers (Basel). 2020 May 27;12(6):1373. doi: 10.3390/cancers12061373.
Cancers (Basel). 2020.
PMID: 32471030
Free PMC article.
Item in Clipboard
Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer.
Grizzi F, Castello A, Qehajaj D, Toschi L, Rossi S, Pistillo D, Paleari V, Veronesi G, Novellis P, Monterisi S, Mineri R, Rahal D, Lopci E.
Grizzi F, et al.
Cancer Immunol Immunother. 2019 Sep;68(9):1537-1545. doi: 10.1007/s00262-019-02387-9. Epub 2019 Sep 3.
Cancer Immunol Immunother. 2019.
PMID: 31482306
Free PMC article.
Item in Clipboard
Cite
Cite